Platinum drugs and neurotoxicity: Effects on intracellular calcium homeostasis

Cell Biology and Toxicology

Volumn 29, Issue 5, 2013, Pages 339-353

  Piccolini, Valeria Maria ^a   Bottone, Maria Grazia ^a,b   Bottiroli, Giovanni ^b   De Pascali, Sandra Angelica ^c   Fanizzi, Francesco Paolo ^c   Bernocchi, Graziella ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

Author keywords

Calcium homeostasis; Cisplatin analogs; CNS development; Immunocytochemistry; Neurotoxicity

Indexed keywords

[PLATINUM (O,O' ACAC)(GAMMA ACAC)(DIMETHYL SULFIDE)]; ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTINEOPLASTIC AGENT; CALBINDIN; CALCIUM; CISPLATIN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOREACTIVITY; NEUROANATOMY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CA2 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CALBINDIN 1; CALCIUM; CISPLATIN; DENTATE GYRUS; HOMEOSTASIS; ORGANOPLATINUM COMPOUNDS; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; RATS; RATS, WISTAR;

EID: 84885298662     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-013-9252-3     Document Type: Article

References (52)

1. Abraham H, Veszpremi B, Kravjak A, Kovacs K, Gomori E, Seress L. Ontogeny of calbindin immunoreactivity in the human hippocampal formation with a special emphasis on granule cells of the dentate gyrus. Int J Dev Neurosci. 2009;27:115-27.
2. Ahmad S. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem Biodivers. 2010;7:543-66.
3. Arain M, Haque M, Johal L, Mathur P, Nel W, Rais A, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449-61.
4. Avella D, Pisu MB, Roda E, Gravati M, Bernocchi G. Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Exp Neurol. 2006;201:131-43. (Pubitemid 44223471)
5. 2+ signals and death programmes in neurons. Philos Trans R Soc Lond B Biol Sci. 2005;360:2255-8. (Pubitemid 46682144)
6. Bernocchi G, Bottone MG, Piccolini VM, Dal Bo V, Santin G, De Pascali SA, et al. Developing central nervous system and vulnerability to platinum compounds. Chemother Res Pract. 2011. doi: 10.1155/2011/315418.
7. Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res. 1986;46:2751-5. (Pubitemid 16074275)
8. Bottone MG, Dal Bo V, Piccolini VM, Bottiroli G, De Pascali SA, Fanizzi FP, et al. Developmental expression of cellular prion protein and apoptotic molecules in the rat cerebellum: effects of platinum compounds. J Chem Neuroanat. 2012;46:19-29.
9. Brandt MD, Jessberger S, Steiner B, Kronenberg G, Reuter K, Bick-Sander A, et al. Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol Cell Neurosci. 2003;24:603-13. (Pubitemid 37506005)
10. Braun K. Calcium-binding proteins in avian and mammalian central nervous system: localization, development and possible functions. Prog Histochem Cytochem. 1990;21:1-64.
11. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2000;18:2695-701. (Pubitemid 30463551)
12. Carafoli E, Brini M. Calcium pumps: structural basis for and mechanism of calcium transmembrane transport. Curr Opin Chem Biol. 2000;4:152-61. (Pubitemid 30189305)
13. Cavaletti G, Marzorati L, Bogliun G, Colombo N, Marzola M, Pittelli MR, et al. Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer. 1992;69:203-7.
14. Cerri S, Piccolini VM, Santin G, Bottone MG, De Pascali SA, Migoni D, et al. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum. Neurotoxicol Teratol. 2011;33:273-81.
15. Chandra S. Quantitative imaging of chemical composition in single cells by secondary Ion mass spectrometry: cisplatin affects calcium stores in renal epithelial cells. Methods Mol Biol. 2010;656:113-30.
16. Danglot L, Triller A, Marty S. The development of hippocampal interneurons in rodents. Hippocampus. 2006;16:1032-60. (Pubitemid 46062830)
17. De Pascali SA, Papadia P, Ciccarese A, Pacifico C, Fanizzi FP. First examples of βdiketonate platinum II complexes with sulfoxide ligands. Eur J Inorg Chem. 2005;5:788-96. (Pubitemid 40343489)
18. De Pascali SA, Papadia P, Capoccia S, Marchiò L, Lanfranchi M, Ciccarese A, et al. Hard/soft selectivity in ligand substitution reactions of β-diketonate platinum(II) complexes. Dalton Trans. 2009;37:7786-95.
19. Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006;5:22.
20. Florea AM, Büsselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals. 2006;19:419-27. (Pubitemid 44081709)
21. Florea AM, Büsselberg D. Anti-cancer drugs interfere with intracellular calcium signaling. Neurotoxicology. 2009;30:803-10.
22. Freund TF, Buszaki G. Interneurons of the hippocampus. Hippocampus. 1996;6:347-470. (Pubitemid 126682925)
23. Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol. 2001;59:657-63. (Pubitemid 32273993)
24. Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1-9.
25. Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci. 2006;100:65-72. (Pubitemid 43161616)
26. Kenyon KA, Bushong EA, Mauer AS, Strehler EE, Weinberg RJ, Burette AC. Cellular and subcellular localization of the neuron-specific plasma membrane calcium ATPase PMCA1a in the rat brain. J Comp Neurol. 2010;518:3169-83.
27. Kip SN, Gray NW, Burette A, Canbay A, Weinberg RJ, Strehler EE. Changes in the expression of plasma membrane calcium extrusion systems during the maturation of hippocampal neurons. Hippocampus. 2006;16:20-34.
28. Liang X, Huang Y. Intracellular free calcium concentration and cisplatin resistance in human lung adenocarcinoma A549 cells. Biosci Rep. 2000;20:129-38.
29. Lohmann C. Calcium signaling and the development of specific neuronal connections. Prog Brain Res. 2009;75:443-52.
30. Magloczky Z, Freund TF. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield. Neuroscience. 1993;56:317-35. (Pubitemid 23274752)
31. Marcos D, Sepulveda MR, Berrocal M, Mata AM. Ontogeny of ATP hydrolysis and isoform expression of the plasma membrane Ca(2+)-ATPase in mouse brain. BMC Neurosci. 2009;10:112.
32. Maskeya D, Pradhanb J, Aryalc B, Leed CM, Choia IY, Parka KS, et al. Chronic 835-MHz radiofrequency exposure to mice hippocampus alters the distribution of calbindin and GFAP immunoreactivity. Brain Res. 2010;1346:237-46.
33. Mata AM, Sepulveda MR. Calcium pumps in the central nervous system. Brain Res Brain Res Rev. 2005;49:398-405. (Pubitemid 41160405)
34. Mata AM, Sepulveda MR. Plasma membrane Ca-ATPases in the nervous system during development and ageing. World J Biol Chem. 2010;1:229-34.
35. Mattson MP. Calcium and neurodegeneration. Aging Cell. 2007;6:337-50. (Pubitemid 46785139)
36. Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology. 1999;20:883-7. (Pubitemid 30091215)
37. Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res. 2012;227:376-9.
38. Muscella A, Calabriso N, De Pascali SA, Urso L, Ciccarese A, Fanizzi FP, et al. New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. Biochem Pharmacol. 2007;74:28-40. (Pubitemid 46802497)
39. Muscella A, Calabriso N, Fanizzi FP, De Pascali SA, Urso L, Ciccarese A, et al. [Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway. Brit J Pharmacol. 2008;153:34-49.
40. Muscella A, Calabriso N, Vetrugno C, Urso L, Fanizzi FP, De Pascali SA, et al. Sublethal concentrations of the platinum(II) complex [Pt(O,O-acac) (gammaacac)(DMS)] alter the motility and induce anoikis in MCF-7 cells. Br J Pharmacol. 2010;160:1362-77.
41. Muscella A, Calabrisio N, Vetrugno C, Fanizzi FP, De Pascali SA, Storelli C, et al. The platinum (II) complex [Pt(O,O′-acac)(gamma-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem Pharmacol. 2011;81:91-103.
42. (2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy. J Neurosci. 2000;20:1831-6. (Pubitemid 30220380)
43. Pisu MB, Roda E, Guioli S, Avella D, Bottone MG, Bernocchi G. Proliferation and migration of granule cells in the developing rat cerebellum: cisplatin effects. Anat Rec A Discov Mol Cell Evol Biol. 2005;287:1226-35. (Pubitemid 43010433)
44. Prestayko AW, D'Aoust JC, Issell BF, Crooke ST. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev. 1979;6:17-35. (Pubitemid 9189580)
45. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33:9-23. (Pubitemid 46137553)
46. Sancho-Martínez SM, Prieto-García L, Prieto M, López-Novoa JM, López-Hernández FJ. Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther. 2012;136:35-55.
47. Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev. 2011;35:729-41.
48. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-79. (Pubitemid 37487159)
49. Sioka C, Kyritsis A. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63:761-7.
50. 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis. Br J Pharmacol. 2007;151:1176-86. (Pubitemid 47255902)
51. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev. 2001;81:21-50. (Pubitemid 32096172)
52. Sugimoto S, Yamamoto YL, Nagahiro S, Diksic M. Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. J Neurooncol. 1995;24:229-40.